4//SEC Filing
Sabus Steve M 4
Accession 0001209191-22-033207
CIK 0001595893other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:02 PM ET
Size
7.3 KB
Accession
0001209191-22-033207
Insider Transaction Report
Form 4
Sabus Steve M
SVP & Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-05-31+165,000→ 165,000 totalExercise: $35.37Exp: 2032-05-30→ Common Stock (165,000 underlying) - Award
Common Stock
2022-05-31+36,667→ 36,667 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]25% of the shares vest on May 31, 2023 and 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001930884
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 5:02 PM ET
- Size
- 7.3 KB